Frost & Sullivan Web Conference on Continuous Glucose Monitoring in Europe: Revolutionizing Diabetes Care

LONDON, April 15, 2010 – According to the International Diabetes Federation the adult population
with diabetes in 2010 is likely to reach 55.2 million in Europe and around
285 million people worldwide. Estimates by the World Health Organisation
(WHO) also record the global increase of diabetes at an alarming rate: By
2030 the number of people with diabetes [...]

Chemotherapy-Induced Neutropenia Can Cause Additional Burden and Risk for Cancer Patients, Pan-European Survey Reveals

Despite availability of prophylactic treatments, nearly a third of patients surveyed experienced an infection during the course of their chemotherapy. Half of patients with an infection required hospitalisation as

THE HAGUE, Netherlands, April 15, 2010 – a result
Thirty percent of patients surveyed experienced an infection as a result
of chemotherapy, 45 percent [...]

D-Pharm Receives Agreement Letter on Special Protocol Assessment for DP-b99 Study – a Pivotal Phase III Trial in Acute Ischemic Stroke Patients

REHOVOT, Israel, April 15, 2010 – D-Pharm Ltd (DPRM: TASE) announced that it has reached an
agreement with the U.S. Food and Drug Administration (FDA) under the Special
Protocol Assessment (SPA) procedure for a pivotal phase 3 trial (MACSI) of
its neuroprotective agent DP-b99 in acute ischemic stroke patients. The SPA
agreement letter indicates that "the design and [...]

Cell Biosciences Launches Two New Platforms

SANTA CLARA, California, April 15, 2010 – Cell Biosciences, Inc., a provider of innovative protein analysis tools
to life science researchers, today announced the launch of two new platforms
for ultrasensitive protein characterization. Both platforms will be unveiled
at the American Association for Cancer Research (AACR) 101st Annual Meeting,
April 17-21, 2010 in Washington, DC (booth 719).

[...]

Growing Threat From Potentially Lethal Diseases Highlighted at Meeting of Global Experts

International Experts at Meeting in New York Call for Vets and Owners to Act

NEW YORK, April 15, 2010 – As experts from around the world met in New York this week they discussed
the need for greater understanding of the threat posed by ticks, fleas and
sand flies. Leading scientists called on veterinarians and dog-owners around
the [...]

Contura Submits Registration Application for Aquamid(R) to the FDA

SOBORG, Denmark, April 15, 2010 – Contura Inc. has submitted a Premarket Approval Application (PMA) for
Aquamid(R) to the U.S. Food and Drug Administration (FDA) requesting
marketing approval in the U.S. for the aesthetic treatment of moderate to
severe facial wrinkles and folds.

The application includes a successful U.S. pivotal study, in which the
safety [...]